Canna Pharma 2021
November 8 – November 10
The Cannabis market is exploding. Yet the state of scientific knowledge on medicinal Cannabis remains immature, and the regulatory environment in North America fragmented and contested. That is why you cannot afford to miss Pharma Ed’s Canna Pharma. This two-day scientific conference will explicitly link current knowledge and practice in the pharmaceutical and Cannabis industries, providing a forum for scientific dialogue and collaboration aimed at advancing best practices in this growing market. Research scientists, analytical experts, drug developers, drug device manufactures, validation experts, cannabis cultivators and processors, Cannabis labs, and public policy makers will come together to advance Cannabis science.
- Two full days of presentations, panel discussions, and networking
- 20 industry experts will share their knowledge and lessons learned
- Full coverage of best practices in Cannabis product development, cultivation, & regulatory compliance
- Key insights from industry working groups-USP, ASTM, and AOAC
- From lab-bench to clinical trials: unlocking the therapeutic potential of Cannabis-derived Compounds
Conference Keynote: Can Cannabis Cure Cancer?
~Donald Abrams, MD, Professor, Dept. of Medicine, UCSF
Method Optimization and Analysis of Cannabis Cartridge Aerosols for 10 Heavy Metals
~Amber Wise, PhD, Scientific Director, Medicine Creek Analytics
Moving Beyond CBD and THC to Maximize API Value from the Right Cannabis/Hemp Genetics
~Reggie Gaudino, PhD, VP of R&D, Front Range Biosciences
Best Practices in Cannabis & Hemp Cultivation
~Hope Jones, PhD, CEO, Emergent Cannabis Sciences
When is “Good Science” Good Enough in the Cannabis Industry?
~Susan Audino, PhD, Instructor/Lead Assessor & Team Leader, American Association for Laboratory Accreditation (A2LA)
Cannabis Extraction: What We’re Doing Wrong & Possible Solutions
~Ethan Russo, MD, CEO & Founder, CReDO Science
AND DON’T MISS OUR NEWLY ADDED PRE-CONFERENCE WORKSHOP!
The Trials and Tribulations of Developing Cannabinoid Drugs: How to Win Regulatory Approval and Bring New Products to Market
Monday, November 8, 2021, 1:00-5:00 PM
Bruce F. Mackler, PhD, JD, EVP of Regulatory & Clinical Affairs & Co-Founder, Ethicann Pharmaceuticals
Brandon J. Price, PhD, EVP of Business Development & Co-Founder, Ethicann Pharmaceuticals
The development of cannabinoid-based pharmaceuticals presents a number of unique challenges to startup companies seeking entry into this new and dynamic market. This Workshop will help corporate management of cannabinoid-based companies, regulatory people, clinical investigators developing research agendas and product pipelines, investors and financial analysts formulate a winning strategy for bringing new Cannabinoid-based products to market.
Click Register Now for Conference and Pre-conference Workshop pricing!
WHAT PEOPLE ARE SAYING ABOUT CANNA PHARMA!
“An amazing program . . .very engaging & greatly informative. Covered areas not well represented yet in Canna events.”
~ Assoc. Director, Vertex Pharmaceuticals
“Excellent Speakers & Content.”
~ Packaging Consultant, Chubby Gorilla
“Very educational & great speakers on the technical side.”
~ Business Development Manager, Extract Technology
“Great speakers, 1st class event all the way around!”
~ General Manager, Avient Biosciences
“This has been a great learning and networking experience.”
~ Engineer, Orion GMP Solutions
DO YOU WORK IN THE CANNABIS INDUSTRY? TAKE ADVANTAGE OF OUR SPECIAL RATE FOR
*CANNABIS INDUSTRY PROFESSIONALS!
*CANNABIS INDUSTRY RATES APPLY TO ORGANIZATIONS THAT WORK MOSTLY OR EXCLUSIVELY IN THE CANNABIS INDUSTRY.
CANNA PHARMA 2021 IS SPONSORED BY
About This Year’s Canna Pharma Summit: Health & Safety First
Driven by breakthroughs in vaccine development and emerging new therapies, the country is inching closer to a new normal. While the situation remains fluid and there is still much work to be done, we are optimistic that we will be able to meet in-person safely later this year.
We are planning Canna Pharma 2021 to be an in-person/hybrid event, enabled by the increased availability of vaccination, the expected decrease in COVID transmissibility, and our ongoing implementation of public health and safety measures. The health and safety of our attendees, sponsors and speakers remains our top priority, and we will endeavor to locate a venue that can ensure the well-being of all. Canna Pharma 2021 will also be live-streamed–the hybrid part–so that anyone who may wish to participate virtually will have the option to do so.